Clinical Trial Update: Pomalidomide as an Immune-enhancing Agent for the Control of HIV [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes testing pomalidomide as an immune-enhancing agent to help control HIV in Phase 1/Phase 2 trials, which is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: University of Aarhus | Conditions: HIV-1 Infection | Phase 1, Phase 2 | Status: RECRUITING